Chronic lymphocytic leukemia in India-A clinico-hematological profile

Hematology

Volumn 12, Issue 3, 2007, Pages 229-233

  Agrawal, Neerja ^a   Naithani, Rahul ^a   Mahapatra, M ^a   Panigrahi, Inusha ^a   Kumar, Rajat ^a   Pati, H P ^a   Saxena, Renu ^a   Choudhary, V P ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Chlorambucil; Leukemia; Lymphadenopathy; Thrombocytopenia

Indexed keywords

CHLORAMBUCIL; CYCLOPHOSPHAMIDE; FLUDARABINE; HEMOGLOBIN;

ADULT; AGE DISTRIBUTION; AGED; ANEMIA; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; BLEEDING; BONE MARROW DISEASE; CANCER MORTALITY; CANCER SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL FEATURE; COUGHING; DISEASE SURVEILLANCE; DRUG RESPONSE; FEMALE; FEVER; HEMOGLOBIN BLOOD LEVEL; HEPATOMEGALY; HUMAN; INDIA; INDIGESTION; LEUKOCYTE COUNT; LYMPHADENOPATHY; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; PALLOR; PRIORITY JOURNAL; SPLENOMEGALY; SURVIVAL TIME; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT; WEAKNESS;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANEMIA; CHLORAMBUCIL; FEMALE; HEMATOLOGIC TESTS; HEPATOMEGALY; HUMANS; INDIA; LEUKEMIA, LYMPHOCYTIC, CHRONIC; LYMPHATIC DISEASES; MALE; MIDDLE AGED; SPLENOMEGALY; SURVIVAL ANALYSIS; THROMBOCYTOPENIA;

EID: 34250625632     PISSN: 10245332     EISSN: 16078454     Source Type: Journal    
DOI: 10.1080/10245330701255064     Document Type: Article

References (18)

1. Foon, KA, Rai, KR and Gale, RP (1990) Chronic lymphocytic leukemia: New insights into biology and therapy. Ann Intern Med, 113, pp. 525-539.
2. O'Brien, S., Giglio, A del and Keating, M. (1995) Advances in the biology and treatment of B-cell chronic lymphocytic leukemia. Blood, 85, pp. 307-318.
3. Mauro, FR, Foa, R., Giannarelli, D., Cordone, I., Crescenzi, S. and Pescarmona, E. (1999) Clinical characteristics and outcome of young chronic lymphocytic leukemia patients: A single institution study of 204 cases. Blood, 94:2, pp. 448-454.
4. Montserrat, E., Gomis, F., Vallespi, T., Rios, A., Romero, A. and Soler, J. (1991) Presenting features and prognosis of chronic lymphocytic leukemia in younger adults. Blood, 78, pp. 1545-1551.
5. Pangalis, GA, Reverter, JC, Boussiotis, VA and Montserrat, E. (1991) Chronic lymphocytic leukemia in younger adults: Preliminary results of a study based on 454 patients. IWCLL/Working Group. Leuk Lymphoma, 5, p. 175.
6. Dhodapkar, M., Tefferi, A. and Phyliky, RL (1993) Prognostic features and survival in young adults with early/intermediate chronic lymphocytic leukemia (B-CLL): A single institution study. Leukemia, 7, pp. 1232-1235.
7. Molica, S., Brugiatelli, M., Callea, V., Morabito, F., Levato, D., Nobile, F. and Alberti, A. (1994) Comparison of younger versus older B-cell chronic lymphocytic leukemia patients for clinical presentation and prognosis. A retrospective study of 53 cases. Eur J Haematol, 52, pp. 216-221.
8. Cheson, BD, Bennett, JM, Grever, M., Kay, N., Keating, MJ and O'Brien, S. (1996) National Cancer Institute-sponsored working group guidelines for chronic lymphocytic leukemia: Revised guidelines for diagnosis and treatment. Blood, 87:12, pp. 4990-4997.
9. Rai, KR, Sawitsky, A., Cronkite, EP, Chanana, AD, Levy, RN and Pasternak, BS (1975) Clinical staging of chronic lymphocytic leukemia. Blood, 46, pp. 219-234.
10. Brugiatelli, M., Claisse, JF, Lenormand, B., Morabito, F., Callea, V., Malloum, K., Chevret, S., Binet, JL, Dighiero, G. and Travade, P. (1997) Long-term outcome of B-cell chronic lymphocytic leukaemia patients in clinical remission phase evaluated at phenotypic level. Br J Haematol, 97, pp. 113-118.
11. Johnson, S., Smith, AG, Loffler, H., Osby, E., Juliusson, G., Emmerich, B., Wyld, PJ, Hiddemann, W. and The French Cooperative Group on CLL (1996) Multicentre prospective randomised trial of fludarabine versus cyclophosphamide, doxorubicin and prednisone (CAP) for treatment of advanced-stage chronic lymphocytic lekaemia. Lancet, 347, pp. 1432-1438.
12. Keating, MJ, O'Brien, S., Lerner, S., Koller, C., Beran, M., Robertson, LE, Freireich, EJ, Estey, E. and Kantarjian, H. (1998) Long-term follow-up of patients with chronic lymphocytic leukemia (CLL) receiving fludarabine regimens as initial therapy. Blood, 92, pp. 1165-1171.
13. Catovsky, D., Richards, S., Fooks, J. and Hamblin, TJ (1991) CLL trials in the United Kingdom: MRC trial 1, 2 and 3. Leuk Lymphoma, 5, p. 105.
14. Dighiero, G., Maloum, K. and Desablens, B. (1998) Chlorambucil in indolent chronic lymphocytic leukemia. N Engl J Med, 338, pp. 1506-1514.
15. Keller, JW, Knospe, WH, Raney, M., Huguley Jr, CM, Johnson, L. and Bartolucci, AA (1986) Treatment of chronic lymphocytic leukemia using chlorambucil and prednisone with or without cycle active consolidation chemotherapy. Cancer, 58, pp. 1185-1192.
16. Raphael, B., Andersen, JW, Silber, R., Oken, M., Moore, D. and Bennett, J. (1991) Comparison of chlorambucil and prednisone versus cyclophosphamide, vincristine, and prednisone as initial treatment for chronic lymphocytic leukemia: Long-term follow-up of an Eastern Cooperative Oncology Group randomized clinical trial. J Clin Oncol, 9, pp. 770-776.
17. Montserrat, E., Alcala, A., Parody, R., Domingo, A., Garcia-Conde, J. and Bueno, J. (1985) Spanish Cooperative Group for Hematological Malignancies Treatment Spanish Society of Hematology: Treatment of chronic lymphocytic leukemia in advanced stages. Cancer, 56, pp. 2369-2375.
18. Lee, JS, Dixon, DO, Kantarjian, HM, Keating, MJ and Talpaz, M. (1987) Prognosis of chronic lymphocytic leukemia: A multivariate regression analysis of 325 untreated patients. Blood, 69:3, pp. 929-936.